Anthony M. Brown

1.1k total citations
14 papers, 925 citations indexed

About

Anthony M. Brown is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Molecular Medicine. According to data from OpenAlex, Anthony M. Brown has authored 14 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 2 papers in Molecular Medicine. Recurrent topics in Anthony M. Brown's work include Receptor Mechanisms and Signaling (5 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). Anthony M. Brown is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). Anthony M. Brown collaborates with scholars based in United States, United Kingdom and Slovakia. Anthony M. Brown's co-authors include Derek N. Middlemiss, Neil Willetts, Graham J. Riley, David R. Thomas, Tracey Gager, Frank D. King, Stephen E. Clarke, Carol Routledge, Helen Newman and Stephen F. Moss and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Molecular and Cellular Biology and Journal of Medicinal Chemistry.

In The Last Decade

Anthony M. Brown

14 papers receiving 876 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anthony M. Brown United States 11 629 416 123 89 73 14 925
Inna Radzishevsky Israel 19 772 1.2× 428 1.0× 194 1.6× 58 0.7× 24 0.3× 32 1.4k
Jon T. Sack United States 17 656 1.0× 303 0.7× 51 0.4× 62 0.7× 40 0.5× 43 853
Melvyn Baez United States 19 571 0.9× 593 1.4× 49 0.4× 57 0.6× 76 1.0× 29 1.0k
Pratima Thakur United States 12 1.0k 1.6× 524 1.3× 32 0.3× 52 0.6× 34 0.5× 16 1.4k
Lois E. Rabow United States 11 754 1.2× 361 0.9× 98 0.8× 55 0.6× 23 0.3× 12 1.0k
Eric A. Ertel Switzerland 17 620 1.0× 312 0.8× 117 1.0× 41 0.5× 51 0.7× 29 905
Ilaria Zanardi United States 14 322 0.5× 106 0.3× 170 1.4× 44 0.5× 34 0.5× 21 644
Kiyoshi Matsuno Japan 16 576 0.9× 297 0.7× 36 0.3× 65 0.7× 111 1.5× 43 786
Anthony G. Hope United Kingdom 20 779 1.2× 420 1.0× 116 0.9× 10 0.1× 62 0.8× 25 1.1k
Romina Mancusso United States 6 565 0.9× 464 1.1× 20 0.2× 53 0.6× 35 0.5× 7 821

Countries citing papers authored by Anthony M. Brown

Since Specialization
Citations

This map shows the geographic impact of Anthony M. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony M. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony M. Brown more than expected).

Fields of papers citing papers by Anthony M. Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony M. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony M. Brown. The network helps show where Anthony M. Brown may publish in the future.

Co-authorship network of co-authors of Anthony M. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony M. Brown. A scholar is included among the top collaborators of Anthony M. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony M. Brown. Anthony M. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kucherlapati, Melanie H., Kan Yang, Mari Kuraguchi, et al.. (2002). Haploinsufficiency of Flap endonuclease ( Fen1 ) leads to rapid tumor progression. Proceedings of the National Academy of Sciences. 99(15). 9924–9929. 197 indexed citations
2.
Routledge, Carol, Steven M. Bromidge, Stephen F. Moss, et al.. (2000). Characterization of SB‐271046: A potent, selective and orally active 5‐HT6 receptor antagonist. British Journal of Pharmacology. 130(7). 1606–1612. 119 indexed citations
3.
Watson, Jeannette M., A. J. Hunter, Anthony M. Brown, & Derek N. Middlemiss. (1999). In vitro characterisation of the muscarinic receptor partial agonist, sabcomeline, in rat cortical and heart membranes. European Journal of Pharmacology. 370(1). 69–77. 6 indexed citations
4.
Thomas, David R., Derek N. Middlemiss, Stephen G. Taylor, Paul R. Nelson, & Anthony M. Brown. (1999). 5‐CT stimulation of adenylyl cyclase activity in guinea‐pig hippocampus: evidence for involvement of 5‐HT7 and 5‐HT1A receptors. British Journal of Pharmacology. 128(1). 158–164. 58 indexed citations
5.
Pertz, Heinz H., Anthony M. Brown, Tracey Gager, & Alberto J. Kaumann. (1999). Simple O-Acylated Derivatives of Lysergol and Dihydrolysergol-I: Synthesis and Interaction with 5-HT2A, 5-HT2C and 5-HT1B Receptors, and α1 Adrenergic Receptors. Journal of Pharmacy and Pharmacology. 51(3). 319–330. 5 indexed citations
6.
Bromidge, Steven M., Anthony M. Brown, Stephen E. Clarke, et al.. (1999). 5-Chloro-N-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon- amide (SB-271046):  A Potent, Selective, and Orally Bioavailable 5-HT6 Receptor Antagonist. Journal of Medicinal Chemistry. 42(2). 202–205. 148 indexed citations
7.
Thomas, David R., Derek N. Middlemiss, Graham J. Riley, et al.. (1998). Functional characterisation of the human cloned 5‐HT7 receptor (long form); antagonist profile of SB‐258719. British Journal of Pharmacology. 124(6). 1300–1306. 103 indexed citations
8.
Forbes, Ian T., Steven Dabbs, D. Malcolm Duckworth, et al.. (1998). (R)-3,N-Dimethyl-N-[1-methyl-3-(4-methylpiperidin-1-yl)propyl]benzenesulfonamide:  The First Selective 5-HT7Receptor Antagonist. Journal of Medicinal Chemistry. 41(5). 655–657. 86 indexed citations
9.
Thomas, David R., Tracey Gager, Vicky Holland, Anthony M. Brown, & Martyn Wood. (1996). m-Chlorophenylpiperazine (mCPP) is an antagonist at the cloned human 5-HT2B receptor. Neuroreport. 7(9). 1457–1460. 34 indexed citations
10.
Kaumann, Alberto J., Laramie M. Gaster, Frank D. King, & Anthony M. Brown. (1994). Blockade of human atrial 5-HT4 receptors by SB 207710, a selective and high affinity 5-HT4 receptor antagonist. Naunyn-Schmiedeberg s Archives of Pharmacology. 349(5). 546–548. 26 indexed citations
11.
Coupland, George, Anthony M. Brown, & Neil Willetts. (1987). The origin of transfer (oriT) of the conjugative plasmid R46: Characterization by deletion analysis and DNA sequencing. Molecular and General Genetics MGG. 208(1-2). 219–225. 21 indexed citations
12.
Rodland, Karin, Anthony M. Brown, & Bruce E. Magun. (1987). Individual Mouse VL30 Elements Transferred to Rat Cells by Viral Pseudotypes Retain Their Responsiveness to Activators of Protein Kinase C. Molecular and Cellular Biology. 7(6). 2296–2298. 9 indexed citations
13.
Brown, Anthony M. & Neil Willetts. (1981). A physical and genetic map of the IncN plasmid R46. Plasmid. 5(2). 188–201. 84 indexed citations
14.
Brown, Anthony M., J. C. Ellory, James D. Young, & Virgilio L. Lew. (1978). A calcium-activated potassium channel present in foetal red cells of the sheep but absent from reticulocytes and mature red cells. Biochimica et Biophysica Acta (BBA) - Biomembranes. 511(2). 163–175. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026